DCF — ST. JOHN MEDICAL CENTER
Enterprise Value: $-142.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-142.1M
Enterprise Value
$-60.1M
PV of Cash Flows
$-82.1M
PV of Terminal Value
$-132.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $564.2M | $0.2M | 0.0% | $-23.7M | $-21.6M |
| Year 2 | $581.1M | $6.0M | 1.0% | $-18.6M | $-15.4M |
| Year 3 | $598.5M | $12.2M | 2.0% | $-13.2M | $-9.9M |
| Year 4 | $616.5M | $15.6M | 3.0% | $-10.5M | $-7.2M |
| Year 5 | $635.0M | $17.7M | 3.0% | $-9.7M | $-6.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-142.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$547.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.004697888779686907
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5